The private equity market will likely drive IPO volumes higher than 2024, but the strength of the PE market could cap the ...

Yet, despite these trends, global IPO activity declined in 2024, the WFE said — due mainly to the Asia-Pacific region, “which raised the lowest amount in the last five years despite hosting the ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

That's the number of U.S. public companies that basically vanished from the rolls between 1998 and last year, according to the Center for Research in Security Prices. There were many factors at play ...

2025 is predicted to be a breakout year for tech company IPOs (initial public offers) in the Middle East and North Africa ...

The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...

The Indian stock market, experiencing a correction after a period of robust growth, is facing a new challenge: the expiration ...

In the current calendar year, more than 20 firms have listed in the SME segment, with 10 trading below their issue price and ...

Oman reported its largest IPO to date in Q4 with OQ Exploration & Production raising US$2.0b Saudi Arabia continued to ...

Veeda Clinical Research has refiled its draft red herring prospectus for an IPO with SEBI. Founded in 2004, the company ...

Veeda Clinical Research has refiled its IPO papers with SEBI, planning to raise funds through a fresh issue and ...